Medigen Vaccine Biologics Corporation
Prices may be delayed up to 20 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| 6547.TWO | 688520.SS | 002007.SZ | MRNA | 261780.KQ | 688319.SS | |
|---|---|---|---|---|---|---|
| Market cap | 15.63B | 15.35B | 22.75B | 103.15B | 103.62B | 12.12B |
| P/E (TTM) | — | — | 38.9 | — | — | — |
| Forward P/E | 32.6 | 21.9 | 11.1 | -56.4 | — | — |
| Price/book | 4.4 | -22.6 | 2.1 | 15.2 | — | 13.4 |
| Dividend yield | — | — | 7.95% | — | — | — |
| 1-year change | +42.31% | −37.00% | −22.82% | +961.98% | +44.97% | +25.39% |
| Today | −2.16% | +1.02% | −0.95% | +13.11% | −2.90% | +6.03% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 20 min.
Latest news
All 6547.TWO news ›Medigen Vaccine Biologics Corp Collaborates with Substipharm Biologics Expanding ENVACGEN® Enterovirus A71 Vaccine Market in Southeast Asia
/PRNewswire/ -- Medigen Vaccine Biologics Corp (MVC) has signed a regional distribution agreement with the pharmaceutical company Substipharm Biologics to... TAIPEI and GENEVA, Jan. 9, 2025 /PRNewswire/ -- Medigen Vaccine Biologics Corp…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- prnewswire.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 1 articles, not a forecast.